Patient-Reported Outcomes After Chemoradiation in Patients With Anal Cancer: A Qualitative Analysis

Purpose: Pelvic chemoradiation therapy (CRT) is the curative therapy for non-metastatic anal cancer, resulting in excellent survival rates. However, anal cancer survivors may experience diminished quality of life (QOL) due to late toxicities from pelvic CRT. Few studies use patient-reported QOL, and...

Full description

Bibliographic Details
Main Authors: Kelsey L. Corrigan, MD, MPH, Brian De, MD, Michael K. Rooney, MD, Ethan B. Ludmir, MD, Prajnan Das, MD, MS, MPH, Grace L. Smith, MD, PhD, Cullen M. Taniguchi, MD, PhD, Bruce D. Minsky, MD, Eugene J. Koay, MD, PhD, Albert C. Koong, MD, PhD, Emma B. Holliday, MD
Format: Article
Language:English
Published: Elsevier 2022-07-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109422000938